Live Vaccine PULVAK IB H120

Infectious bronchitis of chickens (IB) is a highly contagious viral disease that severely affects the birds’ respiratory system and causes a sharp drop in egg production, leading to significant economic losses for poultry farms. To effectively prevent this disease, Zoetis developed the live dry vaccine PULVAK IB H120. The vaccine is based on the attenuated “H-120” strain (Massachusetts serotype), grown on clean SPF embryos, ensuring targeted protection of the flock against classical IB virus strains.

The main advantage of PULVAK IB H120 for industrial poultry farms is its versatility and ease of mass application. It can be administered enterally (via drinking water), by spray method, or individually (ocular route) starting from day-old chicks. Furthermore, this vaccine can be safely combined with other immunobiological products, allowing veterinarians to flexibly schedule vaccinations, reduce labor costs, and minimize stress for the flock.

Implementing PULVAK IB H120 in your farm’s veterinary protection protocol ensures stable immunity for at least 16 weeks. By preventing damage to the respiratory and reproductive systems, you maintain maximum egg production in layers and healthy growth in broilers. It is a proven investment in biosecurity, protecting your production performance and ensuring stable farm profitability.